Maravai LifeSciences (MRVI) Competitors $5.61 +0.28 (+5.25%) (As of 12/26/2024 05:23 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MRVI vs. BBIO, TGTX, CRNX, ALKS, VKTX, AXSM, APLS, RARE, PBH, and OGNShould you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Crinetics Pharmaceuticals (CRNX), Alkermes (ALKS), Viking Therapeutics (VKTX), Axsome Therapeutics (AXSM), Apellis Pharmaceuticals (APLS), Ultragenyx Pharmaceutical (RARE), Prestige Consumer Healthcare (PBH), and Organon & Co. (OGN). These companies are all part of the "pharmaceutical preparations" industry. Maravai LifeSciences vs. BridgeBio Pharma TG Therapeutics Crinetics Pharmaceuticals Alkermes Viking Therapeutics Axsome Therapeutics Apellis Pharmaceuticals Ultragenyx Pharmaceutical Prestige Consumer Healthcare Organon & Co. BridgeBio Pharma (NASDAQ:BBIO) and Maravai LifeSciences (NASDAQ:MRVI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Which has stronger earnings & valuation, BBIO or MRVI? Maravai LifeSciences has higher revenue and earnings than BridgeBio Pharma. BridgeBio Pharma is trading at a lower price-to-earnings ratio than Maravai LifeSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBridgeBio Pharma$217.77M24.64-$643.20M-$2.41-11.78Maravai LifeSciences$276.92M5.12-$119.03M-$1.64-3.42 Does the media prefer BBIO or MRVI? In the previous week, BridgeBio Pharma had 2 more articles in the media than Maravai LifeSciences. MarketBeat recorded 8 mentions for BridgeBio Pharma and 6 mentions for Maravai LifeSciences. BridgeBio Pharma's average media sentiment score of 0.77 beat Maravai LifeSciences' score of 0.53 indicating that BridgeBio Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BridgeBio Pharma 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Maravai LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer BBIO or MRVI? BridgeBio Pharma received 106 more outperform votes than Maravai LifeSciences when rated by MarketBeat users. Likewise, 71.19% of users gave BridgeBio Pharma an outperform vote while only 62.63% of users gave Maravai LifeSciences an outperform vote. CompanyUnderperformOutperformBridgeBio PharmaOutperform Votes16871.19% Underperform Votes6828.81% Maravai LifeSciencesOutperform Votes6262.63% Underperform Votes3737.37% Do analysts prefer BBIO or MRVI? BridgeBio Pharma presently has a consensus target price of $48.08, indicating a potential upside of 69.34%. Maravai LifeSciences has a consensus target price of $10.28, indicating a potential upside of 83.27%. Given Maravai LifeSciences' higher possible upside, analysts clearly believe Maravai LifeSciences is more favorable than BridgeBio Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BridgeBio Pharma 0 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.86Maravai LifeSciences 1 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.36 Do institutionals and insiders hold more shares of BBIO or MRVI? 99.8% of BridgeBio Pharma shares are held by institutional investors. Comparatively, 50.3% of Maravai LifeSciences shares are held by institutional investors. 24.7% of BridgeBio Pharma shares are held by company insiders. Comparatively, 0.6% of Maravai LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is BBIO or MRVI more profitable? Maravai LifeSciences has a net margin of -81.13% compared to BridgeBio Pharma's net margin of -201.53%. BridgeBio Pharma's return on equity of 0.00% beat Maravai LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets BridgeBio Pharma-201.53% N/A -74.34% Maravai LifeSciences -81.13%-6.61%-3.45% Which has more risk & volatility, BBIO or MRVI? BridgeBio Pharma has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, Maravai LifeSciences has a beta of -0.07, suggesting that its stock price is 107% less volatile than the S&P 500. SummaryBridgeBio Pharma beats Maravai LifeSciences on 11 of the 18 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRVI vs. The Competition Export to ExcelMetricMaravai LifeSciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.42B$6.68B$5.24B$9.26BDividend YieldN/A2.98%5.11%4.26%P/E Ratio-3.4210.6887.6117.33Price / Sales5.12209.011,162.83123.73Price / Cash59.8757.1543.3737.83Price / Book1.795.254.905.06Net Income-$119.03M$150.75M$120.44M$225.13M7 Day Performance4.47%4.44%3.00%4.58%1 Month Performance-5.24%-3.67%16.91%3.45%1 Year Performance-15.77%7.59%27.89%17.94% Maravai LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRVIMaravai LifeSciences4.4996 of 5 stars$5.61+5.3%$10.28+83.3%-15.5%$1.42B$276.92M-3.42580Options VolumeGap DownBBIOBridgeBio Pharma4.5512 of 5 stars$27.44+3.6%$47.69+73.8%-32.4%$5.19B$217.77M-11.39400TGTXTG Therapeutics4.203 of 5 stars$32.42+0.7%$40.67+25.4%+97.2%$5.05B$264.79M-324.17290CRNXCrinetics Pharmaceuticals3.8234 of 5 stars$53.72+0.2%$74.40+38.5%+49.3%$4.98B$1.04M-14.40210Positive NewsALKSAlkermes4.7573 of 5 stars$29.34-1.2%$35.42+20.7%+7.0%$4.75B$1.51B15.052,100Short Interest ↓Positive NewsVKTXViking Therapeutics3.8254 of 5 stars$41.83-1.0%$106.75+155.2%+123.0%$4.66BN/A-44.9820AXSMAxsome Therapeutics4.8224 of 5 stars$87.02-4.1%$125.93+44.7%+10.8%$4.22B$338.46M-13.33589Short Interest ↓APLSApellis Pharmaceuticals4.6744 of 5 stars$33.14-0.2%$49.94+50.7%-45.2%$4.12B$715.22M-16.33702Short Interest ↓RAREUltragenyx Pharmaceutical4.6038 of 5 stars$43.47-1.7%$88.46+103.5%-8.0%$4.01B$522.75M-6.721,276Analyst ForecastPBHPrestige Consumer Healthcare3.8328 of 5 stars$78.26-0.6%$85.25+8.9%+28.3%$3.87B$1.11B19.04540Positive NewsOGNOrganon & Co.4.7721 of 5 stars$14.65+0.5%$21.33+45.6%+5.8%$3.77B$6.41B2.9110,000 Related Companies and Tools Related Companies BBIO Alternatives TGTX Alternatives CRNX Alternatives ALKS Alternatives VKTX Alternatives AXSM Alternatives APLS Alternatives RARE Alternatives PBH Alternatives OGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRVI) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
